Zoloft in shortage due to increased demand during pandemic

The FDA added Zoloft, one of the most commonly prescribed antidepressants in the U.S., to its list of drugs in shortage as demand for the drug has spiked during the COVID-19 pandemic, Bloomberg reports. 

Advertisement

Zoloft is used to treat depression, obsessive-compulsive disorder and post-traumatic stress disorder. Demand for the drug rose 12 percent year over year in March, according to Bloomberg. The FDA added it to its shortage list May 29. 

Generic drugmakers told the FDA they weren’t able to get enough active pharmaceutical ingredients to make the drug. They told Bloomberg they expect the shortage to last for a couple of months. 

Read the full article here.

More articles on pharmacy:
American Pharmacists Association swears in new CEO
5 recent CMS pharmacy policy changes
Sanofi shakes up leadership, brings in 4 new execs

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The Performance Gap Your Pharmacy Training Metrics Can’t See

Monday, August 10
12:00 PM - 1:00 PM CDT

Presenters: Michael Alexander, AudirieDr. Tina Moen, PharmD, Colibri Healthcare

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.